Abstract
Foot-and-mouth disease virus (FMDV) has a positive-sense ssRNA genome including a single, large, open reading frame. Splitting of the encoded polyprotein at the 2A/2B junction is mediated by the 2A peptide (18 residues long), which induces a nonproteolytic, cotranslational “cleavage” at its own C terminus. A conserved feature among variants of 2A is the C-terminal motif N16P17G18/P19, where P19 is the first residue of 2B. It has been shown previously that certain amino acid substitutions can be tolerated at residues E14, S15, and N16 within the 2A sequence of infectious FMDVs, but no variants at residues P17, G18, or P19 have been identified. In this study, using highly degenerate primers, we analyzed if any other residues can be present at each position of the NPG/P motif within infectious FMDV. No alternative forms of this motif were found to be encoded by rescued FMDVs after two, three, or four passages. However, surprisingly, a clear codon preference for the wt nucleotide sequence encoding the NPGP motif within these viruses was observed. Indeed, the codons selected to code for P17 and P19 within this motif were distinct; thus the synonymous codons are not equivalent.
Keywords: picornavirus, synonymous codon, codon bias, translation
INTRODUCTION
Foot-and-mouth disease virus (FMDV) is the prototypic member of the genus Aphthovirus within the family Picornaviridae. This virus is the causative agent of the highly contagious and economically important disease of cloven-hoofed animals, foot-and-mouth disease. The positive-sense ssRNA genome of around 8400 nt includes a single, large, open reading frame (ORF), ∼7000 nt, encoding a polyprotein (Belsham 2005). The full-length viral polyprotein is never observed since it is rapidly processed during and after synthesis mainly by the virus-encoded proteases (primarily 3Cpro) to produce 15 distinct mature proteins plus multiple precursors (for review, see Martinez-Salas and Belsham 2017). Interestingly, FMDV, like many (but by no means all) other picornaviruses (e.g., cardioviruses, erboviruses, teschoviruses, etc.) uses a cotranslational, protease-independent mechanism for the “cleavage” of the polyprotein at the 2A/2B junction (the boundary between the capsid proteins and the nonstructural proteins) (Donnelly et al. 2001a). This mechanism has been referred to as “ribosomal skipping” or, alternatively, “stop-carry on” or “StopGo” (Donnelly et al. 2001a; Atkins et al. 2007; Doronina et al. 2008; Tulloch et al. 2017). The 2A peptide lacks characteristic protease motifs and only mediates “cleavage” during translation. It has been demonstrated that the 2A sequence is able to mediate “cleavage” in all eukaryotic translation systems tested, whereas a number of artificial polyproteins containing this sequence have been examined in prokaryotic systems and no detectable cleavage products were observed (Donnelly et al. 1997).
The 2A peptide contains a highly conserved D12(V/I)E(S/T)NPG2A↓P192B motif at its C terminus, which is critical for its function (Ryan and Drew 1994; Donnelly et al. 1997). This motif, together with upstream amino acids, is believed to interact with the ribosomal exit tunnel. This prevents the formation of a peptide bond between the C-terminal glycine (G18) of 2A and the N-terminal proline of 2B, referred to here as P19 since it is an important part of the cleavage mechanism (see also Ryan et al. 1999; Donnelly et al. 2001a). However, remarkably, protein synthesis continues without the requirement for a reinitiation event.
Investigations into the activity of the 2A sequence have mainly been performed using in vitro experiments. Typically, these have either used mRNAs with single ORFs encoding artificial polyproteins comprising two reporter proteins linked via the 2A peptide (Ryan et al. 1991; Ryan and Drew 1994; Donnelly et al. 2001b) or by expressing cDNAs encoding a truncated viral polyprotein including the StopGo coding region (Palmenberg et al. 1992). Alterations to the conserved D12(V/I)E(S/T)NPG2A↓P192B motif reduced or abrogated the StopGo function (Donnelly et al. 2001b; Sharma et al. 2012), thereby showing that these amino acids are important for the correct StopGo “cleavage.” Furthermore, Hahn and Palmenberg (1996) demonstrated that alterations to this motif also influenced the viability of encephalomyocarditis virus (EMCV, a cardiovirus) as they resulted in lethal phenotypes. Subsequently, Loughran et al. (2013) reported a similar observation for FMDV, as modification of the S15NPG182A↓P192B sequence to S15NPL182A↓V192B or S15NPA182A↓P192B also gave rise to a lethal phenotype.
However, recently, certain amino acid substitutions (e.g., 2A S15 to F/I and 2A N16 to H) that have been shown to severely (60%–70%) impair “cleavage” at the 2A/2B junction, using in vitro assays (Donnelly et al. 2001b), have been found to be tolerated within infectious FMDVs (J Kjær and GJ Belsham, in prep.). In contrast, other substitutions (e.g., P19 to A and P19 to G) that inhibit cleavage more severely (by 89%–100%) in vitro, were not found within rescued viruses. Indeed, viruses rescued from these mutant transcripts had sequences that exactly matched the wt sequence (i.e., the rescued viruses were not mutant). In these studies, we also determined a critical role for the StopGo mechanism for the overall level of replication/translation of FMDV RNA. FMDV replicons with a defective 2A sequence had a markedly lower replication efficiency compared to the wt replicon (J Kjær and GJ Belsham, in prep.).
It is, therefore, apparent that some amino acid substitutions can be tolerated within the FMDV 2A peptide, whereas other changes are not compatible with viability. To identify if any alternative residues can be accepted within the critical N16P17G182A↓P192B motif, degenerate sequences, encoding all possible amino acid substitutions at each of these positions individually, were introduced into a full-length FMDV cDNA, as used previously (Gullberg et al. 2013; Kristensen et al. 2017). In principle, this should result in the production of RNA transcripts encoding 2A peptides with a wide spectrum of “cleavage” activities. This was achieved by generating a large pool of plasmids, using site-directed mutagenesis with highly degenerate oligonucleotides, to change each of the individual codons corresponding to the amino acid residues within this conserved motif to NNN (where N is a mixture of all four bases). Using each pool of plasmids, RNA transcripts were prepared in vitro and introduced into baby hamster kidney (BHK) cells. Infectious viruses were rescued and characterized.
RESULTS AND DISCUSSION
The expected generation of a pool of StopGo cDNA mutants that could potentially result in all possible single amino substitutions in place of the N16, P17, G18, and P19 residues (see Fig. 1A) was analyzed by sequencing (see Fig. 1B). The heterogeneity at the expected positions was clear in each case (this does not prove that each of the possible codons was present but indicates it is likely).
FIGURE 1.
Structure of the FMDV O1 Kaufbeuren (O1K) cDNA and its derivatives. (A) The plasmid-encoded amino acids and the corresponding nucleotide sequences at the 2A/2B junction are shown. The FMDV O1K degenerate codon mutants were produced as described in the text using the mutant pT7S3 plasmids encoding the N16A, P17A, G18A, and P19A substitutions as templates. The full-length plasmid pools were linearized using HpaI prior to in vitro transcription and virus rescue. The locations of the HpaI and ApaI restriction sites that were used are marked. (N) A mixture of the 4 nucleotides. (B) Chromatograms and sequences of the FMDV cDNA corresponding to the NPGP motif at the 2A/2B junction. Degenerate positions showing the presence of multiple nucleotides are marked with an N (in bold type). The color code in the chromatograms is as follows: A (red), T (green), G (yellow), C (blue).
Full-length RNA transcripts were produced in vitro and introduced into BHK cells. Infectious virus was generated and passaged in fresh cells. RNA was then extracted from the virus harvests and the sequence encoding the 2A peptide was amplified by RT-PCR. The pool of amplicons was introduced into the pCR-XL-TOPO vector and then the sequence of the inserts in 20 individual colonies was determined for each virus harvest. It was found that all of the rescued viruses analyzed after passages p2, p3, and p4 encoded the wt amino acid sequence at the NPGP motif in 2A. Interestingly, the complete spectrum of the possible synonymous codons for each of the residues N16, P17, G18, and P19 was present in the rescued viral genomes at p2 (see Table 1). These results indicated that the approach had indeed generated a diverse pool of codons within the viruses. Furthermore, the very restricted range of nucleotide sequences encoding 2A observed within the rescued viruses strongly suggests that the specific amino acid sequence (NPGP), encoded by these nucleotide sequences, is critical for FMDV viability.
TABLE 1.
Codon utilization encoding the “NPGP” motif at the 2A/2B junction within rescued FMDVs
However, it was also apparent that the utilization of the different codons for the conserved amino acid residues varied. At p2, 55% of the sequences analyzed had the wt codon for residue N16 (AAC), while the synonymous AAT codon was present in the remaining 45% of the rescued sequences. In the subsequent passages, the proportion of the AAC codon within the sequences increased to 75% and 95% by p3 and p4, respectively, while the incidence of the AAT codon declined (Table 1). For residue P17, at p2, the codon CCT was present in 55% of the colonies analyzed and increased to 100% by p4. Each of the three other possible codons for P17 (CCC, CCA, and CCG) were also observed at p2 but each declined as the wt codon became dominant. For residues G18 and P19, the wt codons (GGG and CCC, respectively) were in the minority (10 or 20%) at p2 and each of the synonymous codons were also present. However, interestingly, by p3 the wt codons had markedly increased to 50% abundance, and by p4 they were dominant (≥90% abundance). For G18, the GGA codon was the most abundant at p2 but declined during further passages to be only 10% of the sequences at p4. Similarly, for P19 the CCT codon was present in 50% of the sequences at p2 but declined to just 5% by p4. Strikingly, by p3, the wt codon was present in 50%–75% of the population at each of the four residues, and by p4 the wt codon was present in 90%–100% of the virus population in each case (Table 1). Thus, it appears that selection occurs for the wt nucleotide sequence during passage of the rescued viruses in cell culture.
The wt GGGCCC nt sequence encoding residues G18 and P19 is recognized in DNA by the restriction enzyme ApaI (see Fig. 1A). Hence, it was possible to deplete the cDNA amplicons generated by RT-PCR, of the wt sequence from the rescued viruses by digesting them with ApaI prior to the cloning step (it was anticipated that this should enhance the detection of non-wt nucleotide sequences). The residual, full-length, 650-bp amplicons were inserted into the pCR-XL-TOPO vector, as described above, and the plasmid DNA from individual colonies was sequenced. As expected, the wt codons for G18 and P19 were no longer observed in the cloned fragments (Table 2) and the G18 (GGA) and P19 (CCT) codons were predominant in these enriched populations. These results are consistent with those obtained without the ApaI digestion (since the GGA and CCT codons were also present in 50% of the fragments at p2 without this treatment, see Table 1), but clearly the apparent abundance of these non-wt codons is enhanced following the ApaI digestion (Table 2), as anticipated. The enrichment for non-wt sequences did not result in the detection of codons for alternative amino acids within the virus population. It had been anticipated that some amino acid substitutions at residue N16 might be rescued since a mutant (with N16 changed to H) has been shown to be viable (J Kjær and GJ Belsham, in prep.) but, presumably, it was outcompeted by the wt virus.
TABLE 2.
Enrichment for non-wt sequences encoding residues G18 and P19 within the “NPGP” motif within rescued FMDVs
It is interesting to note that the G18 (GGA) and P19 (CCT) codons have previously been found to be the second most abundant codons found in FMDV genomes from all seven serotypes (see Gao et al. 2014). This comparison of FMDV sequences also indicated that the alternate codon for N16 (AAC) is present in only a small minority of FMDV genomes and CCC is also a minor population of the codons used for residue P17. The results presented in Table 1 clearly indicate that infectious FMDVs with these synonymous changes can be obtained, but these viruses do not appear to be stably maintained in cell culture and are apparently selected against.
The evidence presented here strongly suggests that there is a distinct selection, within the virus when grown in cell culture, for codon AAC for N16, CCT for P17, GGG for G18, and CCC for P19; thereby indicating that synonymous codon usage for this conserved motif is biased in these rescued viruses. It is particularly noteworthy that the codon preference for P17 and P19 is different (CCT and CCC, respectively). This raises the question of why does the virus select some codons over others? Various studies have demonstrated that synonymous codon usage bias plays an important role in the translation of certain mRNAs (Bulmer 1991; Akashi 2001; Novoa and Ribas de Pouplana 2012; Mauro and Chappell 2014). It is therefore conceivable that synonymous codons may influence the cleavage efficiency through the FMDV StopGo mechanism. As indicated above, a marked codon bias within the FMDV genome is apparent from the alignment of diverse FMDV 2A sequences, as described by Gao et al. (2014). However, in the context of a synthetic reporter polyprotein, assayed within CHO cells, use of the four different synonymous codons for residue G18 of the 2A peptide resulted in very similar apparent “cleavage” efficiencies at the 2A/2B junction. This was interpreted as showing that it is the amino acid residue rather than the nt sequence which is critical for achieving cleavage (Gao et al. 2014). However, using that assay system, the “cleavage” efficiency was only about 88%–89% while essentially 100% cleavage occurs within the native context, as in the virus. The results obtained here (see Table 1) indicate that two separate selection effects may be operating. There is a clear selection for the NPGP motif at the amino acid level. However, in addition, there is a distinct codon bias within the context of the rescued infectious viruses and a significant selection pressure appears to exist for the wt sequence. This effect is fully consistent with the codon bias observed in the analysis of natural FMDV genomic sequences (Gao et al. 2014). This suggests that the FMDV RNA sequence itself (rather than just the encoded amino acid sequence) affects the “cleavage” process (StopGo mechanism) at the 2A/2B junction. Such an effect could be achieved through a direct interaction of the RNA sequence itself or potentially through interactions with the specific charged tRNAs involved in the translation process. In the case of the P17 and P19 codons, it is interesting to note that the same type of prolyl tRNA (with an IGG anticodon) has been reported to be used for decoding of the CCC and CCU codons in human cells (no gene for a tRNA that is cognate for CCC was identified, see Mauro and Chappell 2014). However, in the current database of tRNA sequences from the Lowe laboratory, it appears that in humans, one of 23 genes for prolyl tRNAs has a GGG anticodon with 10 copies having an AGG anticodon. In the mouse genome, one of 20 genes for the prolyl tRNAs has the GGG anticodon and eight genes have the AGG anticodon (see the gtrnadb.ucsc.edu database described in Chan and Lowe 2009). Interestingly, in cattle and pigs (major hosts for FMDV) and also in the rat, there is no gene for a prolyl tRNA with a GGG anticodon. Thus, it is not clear whether a single, post-transcriptionally modified prolyl tRNA recognizes these two Pro codons (at least some of the time) or if different tRNAs are involved in the hamster cells used here. If a single tRNA is involved in recognizing both codons (as in cattle, pigs, and rats), then it seems that the RNA sequence itself must be influencing the StopGo process; it seems unlikely that this effect is mediated through some secondary or tertiary RNA structure, as this would presumably be lost on the ribosome during the process of translation. It will clearly be important to analyze the effect of the presence of the non-optimal synonymous codons on “cleavage” at the 2A/2B junction in its native context.
MATERIALS AND METHODS
Construction of plasmids containing full-length mutant FMDV cDNAs
Pools of StopGo cDNA mutants that potentially result in all possible single amino substitutions in place of the N16, P17, G18, and P19 residues, respectively, were constructed. This was achieved using a two-step site-directed mutagenesis procedure. This is a variation of the QuickChange protocol (Stratagene), using Phusion High-Fidelity DNA Polymerase (Thermo Scientific) with modified versions of the plasmid pT7S3 (Ellard et al. 1999) as template. The wt pT7S3 contains the full-length cDNA for the O1Kaufbeuren B64 strain of FMDV. To eliminate the possibility of carrying over some residual wt template from the PCR, the templates used were modified versions of the pT7S3 with the codons for N16, P17, G18, or P19 changed to encode an alanine (A) residue in each case (see Fig. 1A). These substitutions have been reported previously to result in a complete loss of apparent cleavage activity (Donnelly et al. 2001b; Sharma et al. 2012) and it has not been possible to rescue infectious virus containing these substitutions (J Kjær and GJ Belsham, in prep.). The first round of PCRs used the forward mutagenic 2A PCR primers (Table 3), with a single reverse primer 8APN206 (Table 3) plus the four different modified pT7S3 plasmids as templates and generated amplicons of approximately 450 bp. These primary PCR products were then used as megaprimers for a second round of PCR with the respective mutant pT7S3 plasmids as templates to produce full-length plasmids. Following DpnI digestion, the products from each reaction were introduced into E. coli and grown as separate pools. The plasmid pools were sequenced using a BigDye Terminator v. 3.1 Cycle Sequencing Kit and a 3500 Genetic Analyzer (Applied Biosystems).
TABLE 3.
Primers used to create and sequence mutant FMDV cDNAs
Rescue of virus from full-length cDNA plasmids
Plasmid DNA isolated from each pool was linearized by digestion with HpaI and RNA transcripts were prepared using T7 RNA polymerase (Ambion T7 MEGAscript) at 37°C for 4 h. The integrity of the transcripts was assessed on agarose gels and quantified by spectrophotometry (NanoDrop 1000, Thermo Scientific), after which they were introduced into BHK cells by electroporation, as described previously (Nayak et al. 2005). The BHK cells were maintained in Dulbecco's modified Eagle medium (DMEM) supplemented with 5% fetal calf serum, and incubated at 37°C with 5% CO2. At 2 d post-electroporation, the viruses were harvested by freezing and then amplified through three passages (p2, p3, and p4) in BHK cells.
Characterization of viruses following multiple passages
After each passage, viral RNA was extracted from a sample of the virus harvest (using the RNeasy Mini Kit, QIAGEN) and converted to cDNA using ready-to-go you-prime first-strand beads (GE Healthcare Life Sciences). FMDV cDNA, which included the whole 2A coding region, was amplified in PCRs (AmpliTaq Gold DNA polymerase, Thermo Scientific) using primers 8APN206 and 8APN203 (see Table 3; Fig. 1). Control reactions, without RT, were used to ensure that the analyzed products were derived from RNA and not from the presence of carryover plasmid DNA template. The amplicons (approximately 650 bp) were visualized on 1% agarose gels and purified (GeneJET Gel Extraction Kit, Thermo Scientific). These amplicons should be representative of the heterogeneity present in the rescued virus populations. The resulting collections of fragments were inserted into pCR-XL-TOPO (Thermo Scientific), and the sequence of the cDNA fragment present in individual bacterial clones (20 colonies for each of the four residues) was determined using the same reverse primer as used for the PCR. The fragments from codon mutants G18 and P19 were also enriched for the non-wt sequence populations by digestion of the cDNA with ApaI prior to gel purification and insertion into the pCR-XL-TOPO vector as described above.
ACKNOWLEDGMENTS
We thank Preben Normann for excellent technical assistance. The studies were supported by core funds within DTU-Vet.
Footnotes
Article is online at http://www.rnajournal.org/cgi/doi/10.1261/rna.063339.117.
REFERENCES
- Akashi H. 2001. Gene expression and molecular evolution. Curr Opin Genet Dev 11: 660–666. [DOI] [PubMed] [Google Scholar]
- Atkins JF, Wills NM, Loughran G, Wu CY, Parsawar K, Ryan MD, Wang CH, Nelson CC. 2007. A case for “StopGo”: reprogramming translation to augment codon meaning of GGN by promoting unconventional termination (Stop) after addition of glycine and then allowing continued translation (Go). RNA 13: 803–810. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Belsham GJ. 2005. Translation and replication of FMDV RNA. Curr Top Microbiol Immunol 288: 43–70. [DOI] [PubMed] [Google Scholar]
- Bulmer M. 1991. The selection-mutation-drift theory of synonymous codon usage. Genetics 129: 897–907. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chan PP, Lowe TM. 2009. GtRNAdb: a database of transfer RNA genes detected in genomic sequence. Nucl Acids Res 37: D93–D97. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Donnelly ML, Gani D, Flint M, Monaghan S, Ryan MD. 1997. The cleavage activities of aphthovirus and cardiovirus 2A proteins. J Gen Virol 78: 13–21. [DOI] [PubMed] [Google Scholar]
- Donnelly ML, Luke G, Mehrotra A, Li X, Hughes LE, Gani D, Ryan MD. 2001a. Analysis of the aphthovirus 2A/2B polyprotein “cleavage” mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal “skip.” J Gen Virol 82: 1013–1025. [DOI] [PubMed] [Google Scholar]
- Donnelly ML, Luke GA, Hughes LE, Luke G, Mendoza H, Dam E, Gani D, Ryan MD. 2001b. The “cleavage” activities of foot-and-mouth disease virus 2A site-directed mutants and naturally occurring “2A-like” sequences. J Gen Virol 82: 1027–1041. [DOI] [PubMed] [Google Scholar]
- Doronina VA, Wu C, de Felipe P, Sachs MS, Ryan MD, Brown JD. 2008. Site-specific release of nascent chains from ribosomes at a sense codon. Mol Cell Biol 28: 4227–4239. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ellard FM, Drew J, Blakemore WE, Stuart DI, King AMQ. 1999. Evidence for the role of His 142 of protein 1C in the acid induced disassembly of foot and mouth disease virus capsids. J Gen Virol 80: 1911–1918. [DOI] [PubMed] [Google Scholar]
- Gao ZL, Zhou JH, Zhang J, Ding YZ, Liu YS. 2014. The silent point mutations at the cleavage site of 2A/2B have no effect on the self-cleavage activity of 2A of foot-and-mouth disease virus. Infect Genet Evol 28: 101–106. [DOI] [PubMed] [Google Scholar]
- Gullberg M, Polacek C, Bøtner A, Belsham GJ. 2013. Processing of the VP1/2A junction is not necessary for production of foot-and-mouth disease virus empty capsids and infectious viruses: characterization of “self-tagged” particles. J Virol 87: 11591–11603. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hahn H, Palmenberg AC. 1996. Mutational analysis of the encephalomyocarditis virus primary cleavage. J Virol 70: 6870–6875. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kristensen T, Normann P, Gullberg M, Fahnøe U, Polacek C, Rasmussen TB, Belsham GJ. 2017. Determinants of the VP1/2A junction cleavage by the 3C protease in foot-and-mouth disease virus-infected cells. J Gen Virol 98: 385–395. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Loughran G, Libbey JE, Uddowla S, Scallan MF, Ryan MD, Fujinami RS, Rieder E, Atkins JF. 2013. Theiler's murine encephalomyelitis virus contrasts with encephalomyocarditis and foot-and-mouth disease viruses in its functional utilization of the StopGo non-standard translation mechanism. J Gen Virol 94: 348–353. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Martinez-Salas E, Belsham GJ. 2017. Genome organisation, translation and replication of foot-and-mouth disease virus RNA. In Foot-and-mouth disease: current research and emerging trends (ed. Sobrino F, Domingo E), pp. 13–42. Caister Academic Press, Poole, UK. [Google Scholar]
- Mauro VP, Chappell SA. 2014. A critical analysis of codon optimization in human therapeutics. Trends Mol Med 20: 604–613. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nayak A, Goodfellow IG, Belsham GJ. 2005. Factors required for the Uridylylation of the foot-and-mouth disease virus 3B1, 3B2, and 3B3 peptides by the RNA-dependent RNA polymerase (3Dpol) in vitro. J Virol 79: 7698–7706. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Novoa EM, Ribas de Pouplana L. 2012. Speeding with control: codon usage, tRNAs, and ribosomes. Trends Genet 28: 574–581. [DOI] [PubMed] [Google Scholar]
- Palmenberg AC, Parks GD, Hall DJ, Ingraham RH, Seng TW, Pallal PV. 1992. Proteolytic processing of the cardioviral P2 region: primary 2A/2B cleavage in clone-derived precursors. Virology 190: 754–762. [DOI] [PubMed] [Google Scholar]
- Ryan MD, Drew J. 1994. Foot-and-mouth disease virus 2A oligopeptide mediated cleavage of an artificial polyprotein. EMBO J 13: 928–933. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ryan MD, King AMQ, Thomas GP. 1991. Cleavage of foot-and-mouth disease virus polyprotein is mediated by residues located within a 19 amino acid sequence. J Gen Virol 72: 2727–2732. [DOI] [PubMed] [Google Scholar]
- Ryan MD, Donnelly M, Lewis A, Mehrotra AP, Wilkie J, Gani D. 1999. A model for nonstoichiometric, cotranslational protein scission in eukaryotic ribosomes. Bioorg Chem 27: 55–79. [Google Scholar]
- Sharma P, Yan F, Doronina VA, Escuin-Ordinas H, Ryan MD, Brown JD. 2012. 2A peptides provide distinct solutions to driving stop-carry on translational recoding. Nucleic Acids Res 40: 3143–3151. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tulloch F, Luke GA, Ryan MD. 2017. Foot-and-mouth disease virus proteinases and polyprotein processing. In Foot-and-mouth disease: current research and emerging trends (ed. Sobrino F, Domingo E), pp. 43–59. Caister Academic Press, Poole, UK. [Google Scholar]